预防急性肾炎合并症 这一点很关键!

2017-11-23 袁壮 薛辛东 儿科急重症与疑难病例诊治评述

急性肾小球肾炎简称急性肾炎,是小儿常见病。在急性期常发生严重并发症,如高血压脑病、心衰等。急性肾炎高血压脑病与其他神经系统疾病的脑症状不同。它是因体内血容量增高引起的,经过1~2周后,尿量开始增多,水肿消退,血压会迅速恢复正常。因此,要应用强有力的速效利尿剂、降压药,迅速利尿、降压、对症止痉,高血压脑病则临床症状会迅速好转。

急性肾小球肾炎简称急性肾炎,是小儿常见病。在急性期常发生严重并发症,如高血压脑病、心衰等。急性肾炎高血压脑病与其他神经系统疾病的脑症状不同。它是因体内血容量增高引起的,经过1~2周后,尿量开始增多,水肿消退,血压会迅速恢复正常。因此,要应用强有力的速效利尿剂、降压药,迅速利尿、降压、对症止痉,高血压脑病则临床症状会迅速好转。

【病例介绍】

张××,女,10岁。入院前二周自觉乏力、不适,4天前晨起眼睑水肿,尿色红。注射青霉素80万单位连续二天,面部水肿加重,并出现尿少,去医院检查测血压18/12 kPa(135/90mmHg),尿化验RBC++++,蛋白++,诊断急性肾炎。注射速尿,口服降压片,次日尿少,每日少于300ml,并出现头痛、恶心,来院前突然发生抽搐持续5分钟左右,急诊收入院。

体格检查:T 36﹒8℃,Bp 20/14 kPa(150/105mmHg),呼吸平稳,意识不清,躁动不安,查体不合作,面色潮红伴有明显水肿,瞳孔等大正圆,光反应良好,心音纯整,心率100次/分,两肺清,肝脾未触及,下肢水肿轻度指压痕,颈软,克氏征阴性,双膝反射正常,踝阵挛阴性。

辅助检查:Hb 115g/L,RBC 4﹒5 ×10 12/L,白细胞10 ×10 9/L,N 0﹒60,L 0﹒40,尿常规检查:尿蛋白++,RBC 满视野,WBC4~5/HP,上皮2~5/HP,颗粒管型0~1/HP。血沉100mmH 2 0,血钾4.0mmol/L,血钠130mmol/L,血氯96mmol/L,血浆总蛋白60g/L,白蛋白40g/L,球蛋白20g/L,胆固醇3.5mmol/L,血尿素氮7.2mmol/L,血肌酐80μmol/L,血气分析:pH 7﹒35,HCO 3 -22mmol/L。

入院诊断:急性肾炎合并高血压脑病

【治疗措施】

1﹒入院后因有意识不清,躁动不安,立即吸氧,减轻脑细胞乏氧。止痉,用5%水合氯醛,30ml,注肛。

2﹒入院后测血压22/15kPa(165/113mmHg),在止痉同时立即肌注利血平2.0mg,20分钟后血压仍为22/15kPa,并采用硝普钠20mg 溶于100ml 葡萄糖液内静脉点滴,以1μg/kg﹒分钟速度持续静脉点滴,依血压情况调节速度(用输液泵维持),用药5分钟后血压开始下降。

3﹒在止痉降压的同时,积极利尿,用速尿静脉注入,每次用速尿40mg,15分钟后又加倍80mg 静脉注入。

经上述治疗,患儿于入院后1小时,能安静入睡,用硝普钠持续治疗三天,血压维持在17/10kPa(128/75mmHg)左右,用速尿60mg 每日2次,三天后尿量开始增多,意识转清,住院2周,尿量正常,水肿消退,血压平稳恢复正常。

【诊治评述】

1﹒根据病史及发病年龄,既往无肾脏病史,突然出现少尿、水肿、高血压,继之尿少,水肿加重,血压持续增高,在病后4天突然出现抽搐、昏迷,结合实验室检查,尿红细胞增多,血尿素氮、肌酐有所增高,诊断急性肾炎高血压脑病是确切的。

2﹒据发病突然加重伴有抽搐,昏迷持续2~3天好转,应与病毒性脑炎及化脓性脑膜炎相鉴别。只要认真详细地询问病史和体格检查,这些疾病相互鉴别并不困难。高血压脑病与其他脑症状不同,它是在血压持续增高的基础上超过18/12kPa(135/90mmHg),出现中枢神经系统的症状,血压下降后,脑症状自然恢复。而血压增高又是在急性肾炎全身血容量增高的状态下形成的,因而当利尿后尿量增多,水肿消退,血压即自行下降,而不留任何后遗症。本例在发病前及发病过程中具有上述的特点,虽然未作脑脊液的检查,从发病的过程,即可除外其他神经系统疾病。

3﹒急性肾炎的急性期(一般在发病后一周)凡有少尿、水肿、高血压临床表现者,即应使用利尿剂,予双氢克尿噻或速尿等口服。早期应用及时能防止循环充血,及高血压脑病的发生,因为造成高血压脑病的主要原因是水钠潴留,血容量增高,在血压急剧增高时,水肿加重,更应当采用强有力的速效利尿剂,如速尿(1mg/kg?次,也可加倍增加)。本例应用速尿60mg 每日二次静脉注射效果较好。如果血压增高,形成脑水肿,有时可形成脑疝,此时立即应用甘露醇降低脑压,减轻脑水肿。本例因入院后血压高,用硝普钠后血压逐渐下降,使用速尿即降脑压又减轻周身血容量,达到利尿、降压的作用。

4﹒急性肾炎有80%左右的病例有高血压,收缩压不超过18kPa(135mmHg),舒张压不超过12kPa(90mmHg)者,可暂时观察,并强调休息和低钠饮食,如血压迅速升高超过上述水平,甚至出现自觉症状,则应给予降压药治疗。常用利血平,可按0.07mg/kg?次肌肉或静脉注射(总量不超过2.0mg),必要时12小时可重复一次,用首剂后一般可给口服,按0.02~0.03mg/kg?d 计算,分2~3次口服。副作用为鼻塞、面红、乏力、心动过速等,停药后即可消除。利血平效果不满意时可并用肼苯达嗪0.2mg/kg,肌注或0.5mg/kg?d,分次口服。对严重高血压或发生高血压脑病者应迅速降压。目前主张首选氯苯甲噻二嗪,用量3~5mg/kg?次。快速静脉注射,效果不满意可1小时重复1次。此药直接作用小动脉平滑肌,用药后1~2分钟即起作用。可持续4~12小时,副作用不明显。当今常见的硝普钠用量以1μg/kg﹒分钟速度持续静脉点滴,在用药后1~2分钟即见血压下降。本例应用硝普钠效果满意,要注意点滴速度,必须维持恒定。药品宜新鲜配制,输液瓶应以黑纸包裹避光。

此外,已沿用多年的硫酸镁仍不失为有效的降压药。肌注时用25%溶液0.2~0.4ml/kg?次,急症时可按100mg/kg 计算,一半稀释为12.5%溶液20分钟内缓慢静脉注射,另一半稀释为1%~5%溶液继续静脉点滴。此药有效量与中毒量相近,可引起呼吸中枢的抑制,并影响心脏、肌肉及神经活动。静脉用药时必须严密观察患儿神志、呼吸、脉搏及血压,每10~15分钟记录一次。若注射过程中血压已下降接近正常,则不待总量注射完毕即应停药。镁中毒的拮抗剂为钙,当血压急剧下降、昏睡、呼吸减慢时,立即静脉注射钙剂5~10ml 解救,无尿患者禁用硫酸镁。

【临床经验】

1﹒急性肾炎引起合并症的主要原因是水钠潴留,血容量增高。因而在发病早期应积极利尿,减轻水钠潴留,提高认识,严密观察患儿,减少并发症的发生,利尿是最关键的。本例发病早期未重视利尿问题,值得注意。

2﹒出现高血压脑病,有抽搐昏迷等症状,应及时查眼底,观察小动脉痉挛程度,以利于用药,同时也可预防脑疝的发生。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-25 villahu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-24 神功盖世

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-23 131****1460

    学习了受益匪浅

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-23 1ddf0692m34(暂无匿称)

    学习了.好文章

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-23 sunfeifeiyang

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1825840, encodeId=671d18258401e, content=<a href='/topic/show?id=c52d388137b' target=_blank style='color:#2F92EE;'>#合并症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38813, encryptionId=c52d388137b, topicName=合并症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Sun Mar 25 03:49:00 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532242, encodeId=396a1532242cc, content=<a href='/topic/show?id=10b5825e4aa' target=_blank style='color:#2F92EE;'>#肾炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82574, encryptionId=10b5825e4aa, topicName=肾炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84df12331144, createdName=villahu, createdTime=Sat Nov 25 02:49:00 CST 2017, time=2017-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263778, encodeId=78b3263e783d, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Nov 24 00:16:52 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263705, encodeId=97ae263e0551, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Thu Nov 23 19:30:14 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263674, encodeId=94e02636e475, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Nov 23 17:12:40 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263617, encodeId=c6c426361e3c, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Thu Nov 23 13:26:27 CST 2017, time=2017-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263600, encodeId=9dfb263600c6, content=jiejiele, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27762113155, createdName=小铭的皮普, createdTime=Thu Nov 23 12:13:13 CST 2017, time=2017-11-23, status=1, ipAttribution=)]
    2017-11-23 小铭的皮普

    jiejiele

    0